LeonaBio, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 5, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 19, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Aug 17, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Jul 30, 2026 | Citizens | upgrade | Market Perform → Market Outperform | — | 47% |
| May 27, 2026 | Piper Sandler | initiate | — → Overweight | — | 54% |
| Feb 19, 2026 | Mizuho | upgrade | Neutral → Outperform | $10 | 52% |
No cross-platform signals in the last 90 days